Ariad Pharmaceuticals Inc fka ARIA

[AK-PROARIAD]

The valuation is in its potential and probability of reaching fruition as with everything in the market. This isn't real estate that it has an absolute value today. Do you think that with RIDA and PONA results so far, we wont get approval. With patents lasting 17 years (from time of submission or approval) these drugs alone will provide revenues for years WHEN APPROVED. Lets say 300 million/year for RIDA and 600 Million/year for Pona. We are looking at close to 1 billion per year for whatever remains of the patent timeframe. We haven't added 113 into the mix. I think 6 billion today is reasonable.